Viemed HealthcareNASDAQ: VMD

Upgraded Viemed Healthcare to 'Buy' due to bullish technicals, strong Q2 earnings, and promising growth trends in ventilator and sleep businesses. Bullish MACD crossover and strong buying volume signal potential for sustained share price increase. Q2 revenue hit $55 million, with notable organic growth and successful sales force restructuring driving performance.

LAFAYETTE, La., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three and six months ended June 30, 2024.

LAFAYETTE, La., July 24, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will host its Quarterly Conference Call on Thursday, August 8, 2024 at 11:00 a.m. ET.

Viemed Healthcare, Inc. (NASDAQ:VMD ) Q3 2023 Earnings Conference Call November 2, 2023 11:00 AM ET Company Participants Todd Zehnder - COO Casey Hoyt - CEO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Doug Cooper - Beacon Securities Limited Michael Freeman - Raymond James Operator Greetings, and welcome to Viemed's 3Q 2023 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.

LAFAYETTE, La., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will participate in the following upcoming investor conferences:

Viemed Healthcare's equity stock has consolidated by ~20% after a strong rally, but the company's economic outlook remains unchanged. The acquisition of HMP has added potential value to VMD, expanding its geographical reach and bringing revenue synergies. Viemed Healthcare's Q2 earnings showed strong growth, with sales up 31% YoY, and the company expects continued expansion in FY'23 and FY'24.

Viemed Healthcare collected another quarter of sequential and YoY sales growth. Investors have revised expectations for the company and added $273mm in market cap off March 2022 lows.

LAFAYETTE, La., April 20, 2023 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it will host its Quarterly Conference Call on Tuesday, May 9, 2023 at 11:00 a.m. ET.

If you are looking for stocks that are well positioned to maintain their recent uptrend, Viemed Healthcare, Inc. (VMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.